DE68922336T2 - Sonden für Papilloma-Virus (HPV49, HPV50, HPV54, HPV55), zu diesem Papilloma-Virus genetisch und immunologisch verwandte Produkte und in vitro Methoden zur Diagnose von Papilloma-Virusinfektionen und Herstellung von Antikörpern gegen diese Papilloma-Viren. - Google Patents

Sonden für Papilloma-Virus (HPV49, HPV50, HPV54, HPV55), zu diesem Papilloma-Virus genetisch und immunologisch verwandte Produkte und in vitro Methoden zur Diagnose von Papilloma-Virusinfektionen und Herstellung von Antikörpern gegen diese Papilloma-Viren.

Info

Publication number
DE68922336T2
DE68922336T2 DE68922336T DE68922336T DE68922336T2 DE 68922336 T2 DE68922336 T2 DE 68922336T2 DE 68922336 T DE68922336 T DE 68922336T DE 68922336 T DE68922336 T DE 68922336T DE 68922336 T2 DE68922336 T2 DE 68922336T2
Authority
DE
Germany
Prior art keywords
papilloma virus
papilloma
hpv50
hpv49
hpv55
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68922336T
Other languages
English (en)
Other versions
DE68922336D1 (de
Inventor
Gerard Orth
Michel Favre
Dina Kremsdorf
Gerard Pehau-Arnaudet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8806486A external-priority patent/FR2631341B1/fr
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Publication of DE68922336D1 publication Critical patent/DE68922336D1/de
Application granted granted Critical
Publication of DE68922336T2 publication Critical patent/DE68922336T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
DE68922336T 1988-05-13 1989-05-12 Sonden für Papilloma-Virus (HPV49, HPV50, HPV54, HPV55), zu diesem Papilloma-Virus genetisch und immunologisch verwandte Produkte und in vitro Methoden zur Diagnose von Papilloma-Virusinfektionen und Herstellung von Antikörpern gegen diese Papilloma-Viren. Expired - Lifetime DE68922336T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8806486A FR2631341B1 (fr) 1988-05-13 1988-05-13 Sondes a papillomavirus hpv49, hpv50, hpv54, hpv55 et produits genetiquement et immunologiquement lies a ce papillomavirus hpv49, hpv50, hpv54, hpv55 et procede de diagnostic in vitro d'infections a papillomavirus et d'immunisation in vivo contre ces papillomavirus
FR888808324A FR2632956B2 (fr) 1988-05-13 1988-06-21 Sondes a papillomavirus hpv49, hpv50, hpv54, hpv55; produits genetiquement et immunologiquement lies a ce papillomavirus hpv49, hpv50, hpv54, hpv55; procede de diagnostic in vitro d'infections a papillomavirus et d'immunisation in vivo contre ces papillomavirus

Publications (2)

Publication Number Publication Date
DE68922336D1 DE68922336D1 (de) 1995-06-01
DE68922336T2 true DE68922336T2 (de) 1995-11-09

Family

ID=26226663

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68922336T Expired - Lifetime DE68922336T2 (de) 1988-05-13 1989-05-12 Sonden für Papilloma-Virus (HPV49, HPV50, HPV54, HPV55), zu diesem Papilloma-Virus genetisch und immunologisch verwandte Produkte und in vitro Methoden zur Diagnose von Papilloma-Virusinfektionen und Herstellung von Antikörpern gegen diese Papilloma-Viren.

Country Status (8)

Country Link
US (5) US5342930A (de)
EP (1) EP0342128B1 (de)
JP (2) JPH0235086A (de)
AT (1) ATE121749T1 (de)
DE (1) DE68922336T2 (de)
ES (1) ES2072308T3 (de)
FR (1) FR2632956B2 (de)
HK (1) HK185095A (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5952015A (ja) * 1982-09-14 1984-03-26 Nippon Soiru Kogyo Kk グラウト注入工法およびその装置
FR2632956B2 (fr) * 1988-05-13 1991-07-12 Pasteur Institut Sondes a papillomavirus hpv49, hpv50, hpv54, hpv55; produits genetiquement et immunologiquement lies a ce papillomavirus hpv49, hpv50, hpv54, hpv55; procede de diagnostic in vitro d'infections a papillomavirus et d'immunisation in vivo contre ces papillomavirus
FR2661921B1 (fr) * 1990-05-11 1992-08-07 Pasteur Institut Sonde a papillomavirus (hpv66), notamment pour le diagnostic in vitro d'infections a papillomavirus, pouvant s'accompagner de neoplasies genitales, et produits genetiquement et immunologiquement lies a ce papillomavirus.
GB9113809D0 (en) 1991-06-26 1991-08-14 Cancer Res Campaign Tech Papillomavirus l2 protein
DE69435155D1 (de) 1993-04-30 2008-12-04 Wellstat Biologics Corp Zusuammensetzungen zur Behandlung von Krebs mittels Viren
US6365787B1 (en) * 1994-09-30 2002-04-02 The Johns Hopkins University Compounds for the suppression of HIV TAT transactivation
WO2000024940A1 (en) * 1998-10-28 2000-05-04 Vysis, Inc. Cellular arrays and methods of detecting and using genetic disorder markers
AU778737B2 (en) * 1999-04-14 2004-12-16 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
DE10009143B4 (de) * 2000-02-26 2012-04-26 Eberhard-Karls-Universität Tübingen Universitätsklinikum Nachweis von Humanen Papillomviren
US20030059806A1 (en) * 2001-01-05 2003-03-27 Science & Technology Corporation @ Unm Probes for the detection of human papillomavirus
WO2003068933A2 (en) * 2002-02-14 2003-08-21 Novavax, Inc. Optimization of gene sequences of virus-like particles for expression in insect cells
EP1539245A2 (de) * 2002-06-26 2005-06-15 The Penn State Research Foundation Verfahren und materialien zur behandlung von infektionen mit dem papillomavirus beim menschen
WO2005030041A2 (en) 2003-09-25 2005-04-07 Third Wave Technologies, Inc. Detection of hpv
JP5020825B2 (ja) 2004-12-08 2012-09-05 ジェン−プローブ・インコーポレーテッド 複数型のヒトパピローマウイルスに由来する核酸の検出
US20070031826A1 (en) * 2005-08-05 2007-02-08 My Gene Diagnostic kit for determining the genotype of a human papilloma virus and method of using thereof
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US20100003704A1 (en) 2008-06-13 2010-01-07 Shuling Cheng IN SITU detection of early stages and late stages HPV infection
JP5306683B2 (ja) * 2007-10-31 2013-10-02 シスメックス株式会社 組み込み型ヒトパピローマウイルスの有無の判定方法
US8257916B2 (en) * 2007-10-31 2012-09-04 Sysmex Corporation Method for detecting integrated HPV DNA
EP2427763A4 (de) * 2009-05-07 2013-08-21 Oncohealth Corp Identifikation eines hohen cin2-grades zur erkennung von früh- und spätstadien sowie zum screening und zur diagnose des menschlichen papillomavirus (hpv) und mit diesem assoziierter krebserkrankungen
EP2521914A4 (de) 2010-01-08 2013-07-10 Oncohealth Corp Zellbasierte hpv-immuntests mit hoher durchlaufleistung zur diagnose und abtastung von hpv-assoziierten krebsen
US9376727B2 (en) 2010-05-25 2016-06-28 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically truncated probes

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2524487B1 (fr) * 1982-04-05 1985-11-22 Pasteur Institut Fragments d'adn codant pour des polypeptides contenant au moins un determinant antigenique des papillomavirus, notamment du type hpv 1a et polypeptides correspondants
US4748109A (en) * 1983-07-01 1988-05-31 Baird Phillip J Assay method and reagent to determine antibodies to papillomavirus virions
CA1276575C (fr) * 1984-11-30 1990-11-20 Sylvie Beaudenon Sondes a papillomavirus et procede de diagnostic in vitro d'infections a papillomavirus
FR2593828B2 (fr) * 1986-01-31 1990-05-04 Pasteur Institut Sonde a papillomavirus et procede de diagnostic in-vitro d'infections a papillomavirus
DE3686304T2 (de) * 1985-04-04 1993-02-11 Univ Georgetown Typenspezifische papillomavirus-dns-sequenzen und peptide.
FR2586428B1 (fr) * 1985-08-26 1988-11-25 Pasteur Institut Polypeptides et anticorps, caracteristiques du papillomavirus et leurs applications au diagnostic in vitro, a la prevention et/ou la lutte contre des infections a papillomavirus
EP0243221B1 (de) * 1986-03-21 1992-05-20 Institut Pasteur Bestimmte, von einem Papillomavirus-Genom abgeleitete DNS-Sequenzen, deren Anwendungen für in vitro-diagnostische Zwecke und die Herstellung von Antigenzusammensetzungen
US4849331A (en) * 1987-06-09 1989-07-18 Life Technologies, Inc. Human papillomavirus 44 nucleic acid hybridization probes and methods for employing the same
US4849332A (en) * 1987-05-26 1989-07-18 Life Technologies, Inc. Human papillomavirus 35 nucleic acid hybridization probes and methods for employing the same
US4849334A (en) * 1987-06-09 1989-07-18 Life Technologies, Inc. Human papillomavirus 43 nucleic acid hybridization probes and methods for employing the same
US4908306A (en) * 1987-06-12 1990-03-13 Life Technologies, Inc. Human papillomavirus 56 nucleic acid hybridization probes and methods for employing the same
JPH03503605A (ja) * 1988-04-04 1991-08-15 オンカー　インコーポレーテッド ヒトパピローマウイルス分類法および該方法に使用する核酸プローブ
FR2632956B2 (fr) * 1988-05-13 1991-07-12 Pasteur Institut Sondes a papillomavirus hpv49, hpv50, hpv54, hpv55; produits genetiquement et immunologiquement lies a ce papillomavirus hpv49, hpv50, hpv54, hpv55; procede de diagnostic in vitro d'infections a papillomavirus et d'immunisation in vivo contre ces papillomavirus
US5182377A (en) * 1988-09-09 1993-01-26 Hoffmann-La Roche Inc. Probes for detection of human papillomavirus
CA2052413C (en) * 1990-09-28 2004-07-13 Jeffrey L. Joseph Nucleotides sequences useful as type-specific probes, pcr primers and lcr probes for the amplifications and detection of human papilloma virus, and related kits and methods
IT1244462B (it) * 1990-12-06 1994-07-15 Sclavo Spa Oligonucleotidi sintetici utili per la diagnosi di infezione da tipi diversi di virus del gruppo papilloma e loro utilizzazione

Also Published As

Publication number Publication date
FR2632956B2 (fr) 1991-07-12
DE68922336D1 (de) 1995-06-01
US5342930A (en) 1994-08-30
ATE121749T1 (de) 1995-05-15
EP0342128B1 (de) 1995-04-26
JPH0235086A (ja) 1990-02-05
US5824466A (en) 1998-10-20
EP0342128A1 (de) 1989-11-15
HK185095A (en) 1995-12-15
US5534439A (en) 1996-07-09
ES2072308T3 (es) 1995-07-16
US5591574A (en) 1997-01-07
US5968522A (en) 1999-10-19
FR2632956A2 (fr) 1989-12-22
JP3207389B2 (ja) 2001-09-10
JPH1128088A (ja) 1999-02-02

Similar Documents

Publication Publication Date Title
DE68922336D1 (de) Sonden für Papilloma-Virus (HPV49, HPV50, HPV54, HPV55), zu diesem Papilloma-Virus genetisch und immunologisch verwandte Produkte und in vitro Methoden zur Diagnose von Papilloma-Virusinfektionen und Herstellung von Antikörpern gegen diese Papilloma-Viren.
DE69104380D1 (de) Vom genom des papillomavirus-hpv-39 abgeleitete dns-sequenzen, deren anwendung in der in vitro-diagnose und zur herstellung einer immunogenenzusammensetzung.
Ho et al. Risk of genital human papillomavirus infection in women with human immunodeficiency virus‐induced immunosuppression
ATE152779T1 (de) Verfahren zur diagnose des menschlichen papillome-viruses typ-16 durch ''polymerase chain reaction''
AU3844095A (en) New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
PT874645E (pt) Complexos metalicos contendo grupos perfluoroalquilo e sua utilizacao no diagnostico por rmn
DE3682893D1 (de) Charakteristische polypeptide und antikoerper vom papillomavirus, diagnostische verfahren und dieselben verwendende impfungen.
ATE170221T1 (de) Dns-sequenzen von hpv42 papillomavirus :verwendungsmöglichkeit für diagnose
EP0404161A3 (de) Neisseria-spezifische DNA-Sonden
FI893683A (fi) Ihmisen papilloomavirus tyyppi 57, sen eristetty DNA ja näiden käyttö
IL102615A0 (en) Immunoassay kits and methods for the detection of antibodies
Hu et al. Oxyntic and antral gastritis in the People's Republic of China: diagnosis and relationship to Helicobacter pylori.
ES429967A1 (es) Procedimiento de obtencion de un preparado antigeno.
Yvert et al. Auxotypes and serogroups of penicillinase producing and non-producing strains of Neisseria gonorrhoeae isolated in Franceville, Gabon.
ATE345814T1 (de) Herstellung eines chimeren papillomavirus
AU4502599A (en) Novel (poly)peptides which represent the epitopes of the human herpes virus type 8
WO1993002217A3 (fr) Sondes oligonucleotidiques pour le typage et la detection des papillomavirus humains
SU789831A1 (ru) Устройство дл измерени посто нного тока
ATE49885T1 (de) Avirulenter rabies-impfstoff.
Yu-lung et al. The Scanning Electron Microscopical Investigation on the Spore of Some Species of Pteridophytes
Vidal et al. Relation Between Fatigue Cracking Rate and the Appearance of the Microfractures in an Aluminum Alloy Viewed With the Scanning Electron Microscope
Burke et al. Are combined ELISA and simple/rapid tests alone adequate for the diagnosis of HIV infection?
SU594933A1 (ru) Доильный стакан

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ROCHE DIAGNOSTICS GMBH, 68305 MANNHEIM, DE